Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ted C Judd

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Angewandte Chemie (International Ed. in English)|December 14, 2002
Concise enantioselective synthesis of (+)-FR66979 and (+)-FR900482: dimethyldioxirane-mediated construction of the hydroxylamine hemiketalTed C Judd, Robert M Williams
Organic Letters|October 12, 2002
Synthesis and DNA cross-linking of a phototriggered FR900482 mitosene progenitorTed C Judd, Robert M Williams
The Journal of Organic Chemistry|April 13, 2004
A concise total synthesis of (+)-FR900482 and (+)-FR66979Ted C Judd, Robert M Williams
Chemical Reviews|May 10, 2013
Mitomycinoid alkaloids: mechanism of action, biosynthesis, total syntheses, and synthetic approachesPhillip D Bass, Daniel A Gubler, Ted C Judd, et al.
Organic Letters|December 21, 2004
Structure determination of mycolactone C via total synthesisTed C Judd, Alexander Bischoff, Yoshito Kishi, et al.
Journal of Medicinal Chemistry|June 29, 2011
From fragment screening to in vivo efficacy: optimization of a series of 2-aminoquinolines as potent inhibitors of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1)Yuan Cheng, Ted C Judd, Michael D Bartberger, et al.
ACS Medicinal Chemistry Letters|February 21, 2015
An Orally Available BACE1 Inhibitor That Affords Robust CNS Aβ Reduction without Cardiovascular LiabilitiesYuan Cheng, James Brown, Ted C Judd, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2015
Development of 2-aminooxazoline 3-azaxanthenes as orally efficacious β-secretase inhibitors for the potential treatment of Alzheimer's diseaseJian Jeffrey Chen, Qingyian Liu, Chester Yuan, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Angewandte Chemie (International Ed. in English)|December 14, 2002
Concise enantioselective synthesis of (+)-FR66979 and (+)-FR900482: dimethyldioxirane-mediated construction of the hydroxylamine hemiketalTed C Judd, Robert M Williams
Organic Letters|October 12, 2002
Synthesis and DNA cross-linking of a phototriggered FR900482 mitosene progenitorTed C Judd, Robert M Williams
The Journal of Organic Chemistry|April 13, 2004
A concise total synthesis of (+)-FR900482 and (+)-FR66979Ted C Judd, Robert M Williams
Chemical Reviews|May 10, 2013
Mitomycinoid alkaloids: mechanism of action, biosynthesis, total syntheses, and synthetic approachesPhillip D Bass, Daniel A Gubler, Ted C Judd, et al.
Organic Letters|December 21, 2004
Structure determination of mycolactone C via total synthesisTed C Judd, Alexander Bischoff, Yoshito Kishi, et al.
Journal of Medicinal Chemistry|June 29, 2011
From fragment screening to in vivo efficacy: optimization of a series of 2-aminoquinolines as potent inhibitors of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1)Yuan Cheng, Ted C Judd, Michael D Bartberger, et al.
ACS Medicinal Chemistry Letters|February 21, 2015
An Orally Available BACE1 Inhibitor That Affords Robust CNS Aβ Reduction without Cardiovascular LiabilitiesYuan Cheng, James Brown, Ted C Judd, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2015
Development of 2-aminooxazoline 3-azaxanthenes as orally efficacious β-secretase inhibitors for the potential treatment of Alzheimer's diseaseJian Jeffrey Chen, Qingyian Liu, Chester Yuan, et al.
Pageof 1